Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.63), $0.14 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $165 million versus the consensus estimate of $148 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.